Kel Vin Tan

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Radiology. Imaging cancer

Proceedings of the National Academy of Sciences of the United States of America

Clinical cancer research : an official journal of the American Association for Cancer Research

Gut

University of Hong Kong

La Trobe University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Hong Kong

Hong Kong

Post-Doctoral Fellow :: Diagnostic Radiology

Memorial Sloan Kettering Cancer Center

United States

Visiting Investigator :: Radiology

La Trobe University

Australia

Laboratory Demonstrator/Technical Assistant :: Chemistry and Physics

Education History

La Trobe University

Australia

PHD :: Chemistry and Physics

Publications

Kel Vin Tan
Theranostic Capacity of a Mucin 16-targeted Antibody for Ovarian Cancer. Radiology. Imaging cancer 6 (3) (2024)
Kel Vin Tan
Theranostic Capacity of a Mucin 16-targeted Antibody for Ovarian Cancer. Radiology. Imaging cancer 6 (3) (2024)
Kel Vin Tan
Theranostic Capacity of a Mucin 16-targeted Antibody for Ovarian Cancer. Radiology. Imaging cancer 6 (3) (2024)
Kel Vin Tan
Theranostic Capacity of a Mucin 16-targeted Antibody for Ovarian Cancer. Radiology. Imaging cancer 6 (3) (2024)
Kel Vin Tan
PARP-targeted Meitner-Auger Electron-emitting Radiopharmaceutical for Radioligand Therapy. Radiology. Imaging cancer 5 (6) (2023)
Kel Vin Tan
Imaging Neuroendocrine Prostate Cancer with 89 Zr-labeled Delta-Like Ligand 3. Radiology. Imaging cancer 5 (1) (2023)
Kel Vin Tan
Imaging Neuroendocrine Prostate Cancer with 89 Zr-labeled Delta-Like Ligand 3. Radiology. Imaging cancer 5 (1) (2023)
Cerise Yuen-Ki Chan, David Kung-Chun Chiu, Vincent Wai-Hin Yuen, Cheuk-Ting Law, Bowie Po-Yee Wong, Kelsie Lynn Thu, David Ward Cescon, Isabel Soria-Bretones, Jacinth Wing-Sum Cheu, Derek Lee, Aki Pui-Wah Tse, Misty Shuo Zhang, Kel Vin Tan, Irene Oi-Lin Ng, Pek-Lan Khong, Thomas Chung-Cheung Yau, Mark Robert Bray, Tak Wah Mak, Carmen Chak-Lui Wong
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 119 (32) (2022)
Kel Vin Tan
[ 18 F]rucaparib to Image PARP in Pancreatic Cancer Models. Radiology. Imaging cancer 4 (5) (2022)
Lei Zhou, Ken Ho Yu, Tin-Lok Wong, Zhao Zhang, Chun Ho Chan, Jane Hc Loong, Noelia Che, Hua Jian Yu, Kel Vin Tan, Man Tong, Elly S Ngan, Joshua Wk Ho, Stephianie Ma
Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression. Gut (2021)
Chung Ying Chan, Kel Vin Tan, Bart Cornelissen
PARP Inhibitors in Cancer Diagnosis and Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2020)

Kel Vin Tan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kel Vin Tan